Profound Medical announced promising results from their TULSA-PRO ablation clinical trial in patients with prostate cancer, which was designed to support Profound’s FDA application to market the device in the United States.
In April, Theraclion announced that it had obtained the CE mark for its newly developed SONOVEIN® focused ultrasound system for the treatment of varicose veins.
Cardiawave, a focused ultrasound company with a mission to reduce aortic valve stenosis caused by calcification, will soon begin clinical trials to test its Valvopulse device.
Chairman Neal F. Kassell, MD, accepted an award on behalf of the Foundation for Outstanding Contributions to Virginia Bioscience at the THRiVE 2019 conference.
Longtime Foundation Board Member, Frederic H. Moll, MD, sold his medical robotics company, Auris Health, Inc., to Johnson & Johnson (J&J) for $3.4 billion and was appointed Chief Development Officer at J&J.
Jodi, mother of three, recently appeared on an episode of “The Doctors” to discuss living with essential tremor and the impact focused ultrasound treatment had on her life.
Jeffrey is the first person in North America to participate in a clinical trial at Sunnybrook Health Sciences Centre investigating the use of focused ultrasound to treat OCD.
The OSU Wexner Medical Center announced the start of a clinical trial using focused ultrasound to open the blood-brain barrier in patients with Alzheimer's disease.
A focused ultrasound study for pets, which will help inform how the technology can be used to treat tumors in humans, is being funded by Petco Foundation and Blue Buffalo.
The American Urological Association annual meeting was held May 3-6, where high-intensity focused ultrasound for prostate and kidney applications were featured.
An international group of clinicians determined whether skull density ratio impacted safety or efficacy for essential tremor patients when treated with focused ultrasound.
